课题基金 / 基金详情

Commercial Feasibility of Digital Mental Health Service Recommendation & Payment Platform For Employers

Commercial Feasibility of Digital Mental Health Service Recommendation & Payment Platform For Employers
数字心理健康服务建议的商业可行性
批准号:
10043566
负责人:
金额:
$6.33万
依托单位:
依托单位国家:
英国
项目类别:
Grant for R&D
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
世界上约10%的人口患有精神疾病或其他行为健康障碍。仅在英国,现在就有超过1000万人患有临床级的抑郁症和焦虑症,还没有寻求治疗。尽管新冠肺炎疫情导致全球焦虑和抑郁的患病率上升了25%,但去年仍有150万人被转介到英国国民健康保险制度提供的MH专科服务,比前年的170万人有所下降。[皇家心理医生学会][0]还认为,有一份隐藏的等待名单,23%的患者在第一次转诊后至少还得再等3个月。由于NHS的巨大压力,人们的MH确实存在恶化的风险,因为他们在两次任命之间得不到支持。Syndi希望通过早期干预和个性化的数字支持来支持数百万有MH问题的人。通过使用Syndi自我护理导航平台,我们提供经过临床验证的评估过程,以及内部开发的机器学习系统,该系统提供独立评级的健康服务建议,然后是个人或团体仪表板,提供针对先前评估的进展情况。为了继续Syndi的产品和商业开发,我们现正建议进行一项计划,以评估新的商业模式和推向市场的途径,以推动我们未来的商业化计划。这项计划的重点是评估中小企业客户的可行性,让他们更好地了解公司内部的医疗保健情况,并资助医疗保健服务的成本,以协助他们改善医疗保健服务,以及减低日后使用昂贵的专业服务的风险。我们将通过详细的商业分析和拓展以及深入的用户体验讨论来实现这一点,以确保我们产品的下一步发展适合这一细分市场的需求。我们这个项目的总体目标是为Syndi创造新的收入来源,并支持减少估计的560亿GB(德勤,2022年)英国企业每年因MH问题造成的生产力损失而损失。[0]:https://www.rcpsych.ac.uk/news-and-features/latest-news/detail/2020/10/06/two-fifths-of-patients-waiting-for-mental-health-treatment-forced-to-resort-to-emergency-or-crisis-services
英文摘要
Around 10% of the world's population suffers from mental illness or other behavioural health disorders. In the UK alone, over 10m people now have clinical-level depression and anxiety and have not yet sought care. Last year, 1.5mn people were referred to specialist MH services, provided by the NHS, down from 1.7mn the year before despite the COVID-19 pandemic triggering a 25% increase in the prevalence of anxiety and depression worldwide. The [Royal College of Psychatrists][0] also believes that there is a hidden waiting list of patients with 23% having to wait at least another 3 months after their first referral. Due to the overwhelming pressure on the NHS, there is a real risk of people's MH deteriorating as they are left with no support in between appointments.Syndi is looking to support millions of people with MH issues through early intervention and personalised digital support. Through the use of the Syndi self-care navigation platform, we offer a clinically validated assessment process, and internally developed machine learning system that provides independently rated health service recommendations and then an individual or group dashboard that provides awareness of the progress being made against the previous assessment.In order to continue the product and commercial development of Syndi, we are proposing to undertake a project to assess new business models and routes to market as well enabling our future commercialisation plans.This project will be focused on evaluating the feasibility of SME customers to give them the means to better understand the MH situation within their company as well as subsidise the cost of MH services to help them improve their MH and reduce the risk of costly professional services later. We will do this through detailed commercial analysis and outreach as well as in-depth user experience discussions to ensure that the next evolution of our product is fit for the needs of this market segment.Our overall aim of this project is to create new revenue streams for Syndi and to support the reduction of the estimated £56bn (Deloitte, 2022) lost by British businesses every year through lost productivity caused by MH issues.[0]: https://www.rcpsych.ac.uk/news-and-features/latest-news/detail/2020/10/06/two-fifths-of-patients-waiting-for-mental-health-treatment-forced-to-resort-to-emergency-or-crisis-services
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金